Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 5/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 5/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 5/20 | 0.37 |
| ▸ | SLC5A2 | P31639 | 4/20 | 0.35 |
| ▸ | HK1 | P19367 | 1/20 | 0.35 |
| ▸ | HK2 | P52789 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | LGALS2 | P05162 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9029247 | 0.83 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL9029257 | 0.83 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL10436007 | 0.83 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL27777436 | 0.82 | SLC5A2 (0.45) | SLC5A2 | |
| SCHEMBL10767838 | 0.82 | SLC5A2 (0.45) | SLC5A2 | |
| SCHEMBL27933773 | 0.82 | SLC5A2 (0.45) | SLC5A2 | |
| SCHEMBL17727876 | 0.81 | SMYD2 (0.34) | — | |
| SCHEMBL15681534 | 0.79 | SLC5A2 (0.36) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| SCHEMBL6559094 | 0.79 | SLC6A2 (0.49) | LGALS3LGALS8SLC5A2 | |
| SCHEMBL6559086 | 0.79 | SLC6A2 (0.49) | LGALS3LGALS8SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0357571-B1 | Pyrimidine nucleosides | MEDIVIR AB (SE) | 1996-04-03 | — | — | EP | disclosed |
| EP-0691333-A2 | Pyrimidine derivatives, process for their preparation and their use as precursors | Medivir Aktiebolag (SE) | 1996-01-10 | — | — | EP | disclosed |
| EP-0357571-A2 | Pyrimidine nucleosides | Medivir Aktiebolag (SE) | 1990-03-07 | — | — | EP | disclosed |